Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05144009
Title A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL) (LOTIS-9)
Acronym LOTIS-9
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors ADC Therapeutics S.A.
Age Groups: senior
Covered Countries USA | ITA | ESP

No variant requirements are available.